Related Experiment Video
Updated: Feb 28, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Microparticles in acute coronary syndrome
Chrysostomos A Mavroudis1, Despina Eleftheriou2, Ying Hong2
1Department of Cardiology, Royal Free Hospital, Royal Free London Foundation Trust, United Kingdom.
Background:
Emerging evidence supports the role of cell-derived microparticles (MPs) in the pathophysiology of acute coronary syndrome (ACS).
Objectives:
To explore the relationship between coronary and systemic MP levels, investigate the correlation between MPs, inflammatory markers and Troponin T in patients with ACS.
Methods:
Thirty seven patients with ACS scheduled for percutaneous coronary interventions (PCI) were studied. Eleven patients with stable angina (SA) were included as a control group. AnnexinV+MPs (AnV+MPs) and activated platelet-monocyte aggregates (PMA) from right atrium (RA) and culprit coronary artery (CO) distal to culprit lesion were measured using flow cytometry. High sensitivity C-reactive protein (CRP), Interleukin - 6 (IL-6), tumour necrosis factor - α (TNF-α), serum amyloid A (SAA) and Troponin T were assayed.
Results:
Total and cell specific AnV+MP expression were higher in the ACS group in both the CO and RA, with greater levels detected in the CO. Platelet activation showed positive correlation with Troponin-T and platelet MP in both CO and RA of the ACS group (r=0.4 for both; p=0.04 & p=0.03 respectively). Inflammatory markers levels did not differ between the ACS and SA patients.
Conclusions:
Elevated coronary and systemic MP levels and positive correlation of platelet activation with Troponin-T and platelet MPs suggest a pathogenic role for MPs in ACS.
Insights
Elevated microparticles (MPs) in coronary arteries and blood, particularly platelet MPs, correlate with Troponin T in acute coronary syndrome (ACS) patients, suggesting a role in disease. This highlights MPs as potential biomarkers in ACS.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Biochemistry
Background:
- Cell-derived microparticles (MPs) are increasingly implicated in the pathophysiology of acute coronary syndrome (ACS).
- Understanding the role of MPs in ACS is crucial for developing new diagnostic and therapeutic strategies.
- This study investigates the relationship between coronary and systemic MP levels in ACS patients.
Purpose of the Study:
- To explore the relationship between coronary and systemic microparticle (MP) levels in patients with acute coronary syndrome (ACS).
- To investigate the correlation between MPs, inflammatory markers, and Troponin T in ACS patients.
- To assess the potential pathogenic role of MPs in ACS.
Main Methods:
- Flow cytometry was used to measure AnnexinV+MPs (AnV+MPs) and activated platelet-monocyte aggregates (PMA) in 37 ACS patients and 11 stable angina (SA) controls.
- Measurements were taken from the right atrium (RA) and culprit coronary artery (CO) distal to the lesion.
- Assays for high-sensitivity C-reactive protein (CRP), IL-6, TNF-α, serum amyloid A (SAA), and Troponin T were performed.
Main Results:
- Total and cell-specific AnV+MP expression were significantly higher in ACS patients compared to controls, with elevated levels in both CO and RA.
- Platelet activation positively correlated with Troponin T and platelet MPs in both CO and RA of ACS patients (r=0.4 for both).
- No significant differences in inflammatory marker levels were observed between ACS and SA groups.
Conclusions:
- Elevated coronary and systemic MP levels in ACS patients suggest a pathogenic role.
- The positive correlation between platelet activation, Troponin T, and platelet MPs further supports the involvement of MPs in ACS.
- MPs may serve as valuable biomarkers in the context of acute coronary syndrome.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome V: Nursing Management

